FDA approves lofexidine for opioid withdrawal symptoms.
Kevin W. Chamberlin, PharmD
The FDA recently approved cannabidiol oral solution to treat seizures.
Vabomere combines a carbapenem and a beta-lactamase inhibitor as a treatment for complicated urinary tract infections.
CSL Behring's Kcentra is is currently the only 4-factor PCC available in the United States.